Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Dr. Agarwal’s Health Care Ltd. ( (IN:AGARWALEYE) ) has shared an update.
Dr. Agarwal’s Health Care Limited has scheduled a board meeting on February 3, 2026, to consider and approve its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, and has maintained a trading window closure in line with its insider trading prevention code until 48 hours after the results are announced. The company will follow this with an earnings and analyst conference call on February 4, 2026, where senior management, including the CEO, CFO and Head of Investor Relations, will discuss the financial performance with investors and analysts, underscoring its emphasis on transparency, regulatory compliance and active engagement with the capital markets.
More about Dr. Agarwal’s Health Care Ltd.
Dr. Agarwal’s Health Care Limited operates in the healthcare sector, focusing on eye care services through a network of ophthalmology hospitals and clinics. Listed on both BSE and NSE under the symbol AGARWALEYE, the company targets patients seeking specialized eye treatments and procedures across India, positioning itself as a leading provider in the organized eye care market.
Average Trading Volume: 10,937
Technical Sentiment Signal: Hold
Current Market Cap: 145B INR
See more data about AGARWALEYE stock on TipRanks’ Stock Analysis page.